Σελίδα 1 από 92 Αποτελέσματα
To determine the prevalence of constipation and fecal soiling in obese children, we asked standardized questions during the initial visit to the obesity clinic. In 80 obese children, 23% met the criteria for constipation, and 15% reported fecal soiling. Constipation and soiling are more prevalent in
OBJECTIVE
This study estimates the prevalence of fecal incontinence (FI) in overweight and obese women with urinary incontinence and compares dietary intake in women with and without FI.
METHODS
A total of 336 incontinent and overweight women in the Program to Reduce Incontinence by Diet and
BACKGROUND
Obesity is an emerging risk factor for fecal incontinence (FI). The aim of this study was to characterize pathophysiologic mechanisms of FI in obese patients compared with non-obese patients in a prospective case-matched study.
METHODS
The general characteristics and data of the anorectal
Electrical stimulation of the gastrointestinal (GI) tract is an attractive concept. Since these organs have their own natural pacemakers, the electrical signals they generate can be altered by externally delivering electric currents by intramuscular, serosal, or intraluminal electrodes to specific
OBJECTIVE
To examine changes in the prevalence and severity of urinary incontinence (UI) and fecal incontinence in morbidly obese women undergoing laparoscopic weight loss surgery.
METHODS
In a prospective cohort study, 101 women (aged 20-55 years) with body mass index (BMI) of 40 or more underwent
BACKGROUND
Fecal incontinence is highly prevalent in the general population and especially in risk groups. Obesity is also common and is associated with comorbidities that impair general health and interfere with daily activities. Identifying mutable factors for fecal incontinence, such as stool
OBJECTIVE
Morbid obesity is associated with urinary incontinence (UI). The study purpose was to determine the prevalence of fecal incontinence (FI), its associated risk factors, and its impact on quality of life (QOL) in morbidly obese women.
METHODS
A questionnaire-based study on morbidly obese
OBJECTIVE
Weight-loss has been demonstrated to result in an improvement in fecal incontinence (FI) severity; however, there is a paucity of data addressing the differential impact of FI on the quality of life (QOL) and results of diagnostic testing across BMI categories. We wished to evaluate
OBJECTIVE
To estimate the effect of weight loss on fecal incontinence (FI) severity among overweight and obese women with urinary incontinence, we analyzed data from women randomized to a weight loss intervention or control condition.
METHODS
The modified Fecal Incontinence Severity Index (FISI) was
BACKGROUND
The association between overweight and gastrointestinal symptoms has been recently studied in the literature; however, few studies have evaluated the association between overweight and constipation in adolescents in a community-based sample. The aim of this study was to analyze the
OBJECTIVE
The rapidly increasing prevalence of obesity in children is the most important problem facing pediatricians today. A recent study suggested an association of obesity and constipation in children but lacked a control group for comparison. The objectives of this study were to evaluate the
Determine clinical and manometric parameters associated with success of antegrade continence enemas (ACEs) administered via cecostomy in the treatment of constipation and fecal overflow incontinence.
We performed a retrospective review of clinical symptoms and manometry (colonic and anorectal)
Nine percent of adult women experience episodes of fecal incontinence at least monthly. Fecal incontinence is more common in older women and those with chronic bowel disturbance, diabetes, obesity, prior anal sphincter injury, or urinary incontinence. Fecal incontinence negatively affects quality of
To identify baseline clinical and demographic characteristics associated with clinically important treatment responses in a randomized trial of nonsurgical therapies for fecal incontinence (FI).Women (N = 296) with FI were randomized to loperamide or